Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |